The University of Manchester is to boost its PET (Positron Emission Tomography) scanning research by developing new tracers that could better detect and treat a wide variety of tumours.
The University’s Wolfson Molecular Imaging Centre (WMIC) has appointed cancer imaging specialist Prof Juri Gelovani from MD Anderson, Texas to lead the study.
The investigation will involve clinical studies using several promising new tracers to study tumour proliferation and infiltration. Gelovani’s initial project at the WMIC will involve the development of new fluorine-18 labelled tracers for studying brain tumour activity. These tracers are thought to provide substantially better scan contrast for grading of malignancy than current techniques and will have a great potential for future clinical use.
The WMIC is licensed for the synthesis of PET research tracer products manufactured in their GMP clean room facility. Its research projects will provide more accurate diagnosis of illness and contribute to new treatments for cancer and brain disorders.
Gelovani and the WMIC will also work closely with the Manchester Cancer Research Centre (MCRC), sharing facilities and knowledge to support the MCRC’s aims to be a leading cancer research centre by 2015.